IVD China last week: Siemens Healthineers, Sysmex & Zhiwei Microbiology, Maccura & Shanghai TRANS-AGE, Dian Diagnostics, Dirui

Siemens Healthineers Diagnostics Signs Education Funding Agreement with Shanghai Jiao Tong University School of Medicine

On May 20, the signing ceremony for the “Siemens Healthineers Diagnostics Education Funding Project” was held at Shanghai Jiao Tong University School of Medicine (SJTUSM). The initiative aims to advance cutting-edge technologies in the IVD field, build a deep industry-university-research integration platform, and support medical technology innovation along with clinical translation.

The funding project will support educational development, talent cultivation, and collaborative research between the two parties. By combining Siemens’ global leadership in diagnostic technologies with SJTUSM’s renowned medical education and research capabilities, the collaboration seeks to accelerate the translation of laboratory innovations into clinical practice. This partnership represents a significant step toward fostering next-generation IVD professionals and driving technological progress in China’s diagnostic industry.

Sysmex and Zhiwei Microbiology Sign Strategic Agreement, Ushering in a New Chapter for POCT

On May 20, Sysmex and Beijing BOE Zhiwei Microbiology Technology Co., Ltd. officially signed a strategic cooperation agreement in Shanghai. Leveraging Sysmex’s extensive expertise as a comprehensive clinical testing solution provider and Zhiwei Microbiology’s innovative strengths in all-infection rapid nucleic acid diagnostics, the two parties will focus on the Chinese market. 

Together, they aim to drive high-quality development in China’s precision diagnostics industry by advancing POCT technologies. This partnership marks a significant step forward in integrating complementary capabilities to accelerate innovation and expand access to rapid, accurate molecular diagnostic solutions across clinical settings.

Maccura & Shanghai TRANS-AGE: Strategic Cooperation on Smart Laboratory Ecosystem

On May 22, Maccura and Shanghai TRANS-AGE held a signing ceremony for their strategic cooperation on “Smart Laboratory Ecosystem Integration” at Maccura’s Bio-City campus in Chengdu.

This partnership marks a significant step forward in collaborative innovation within the smart IVD field. As the IVD industry rapidly transitions toward intelligent, automated, and digital solutions, traditional laboratory operations urgently require restructuring. By combining Maccura’s strengths in diagnostic products with TRANS-AGE’s expertise in medical automation and robotics, the two parties aim to jointly develop integrated, high-efficiency smart laboratory solutions. The alliance focuses on creating a seamless ecosystem that enhances workflow automation, data connectivity, and operational precision, ultimately driving the next generation of smart diagnostic laboratories in China.

Dian Diagnostics & Zhejiang CDC: Strategic Framework Agreement for Precision Diagnosis Platform

On May 22, Dian Diagnostics signed a strategic framework cooperation agreement with the Zhejiang Provincial Center for Disease Control and Prevention (Zhejiang CDC). The partnership focuses on building a joint “Precision Diagnosis R&D Platform” leveraging high-end technologies such as pathogen etiology, pathogen microorganism diagnostics, multi-omics, and disease-specific biobanks. 

The collaboration aims to deeply integrate technological and industrial innovation, accelerating the integrated development of “production, education, research and application.” This agreement represents a solid step forward in deepening medical-prevention coordination and precise public health prevention and control. It also marks the beginning of a new chapter in integrating public health system development with third-party medical diagnostics. Through this alliance, Dian Diagnostics and Zhejiang CDC are committed to advancing rapid response capabilities for infectious diseases and fostering innovation in disease prevention and control technologies.

Dirui Clinical Laboratory Launches in Ecuador

Recently, Dirui completed the installation, commissioning, and project acceptance of its total clinical laboratory solution project at a key hospital under Ecuador’s Ministry of Public Health. The project has now officially entered clinical operation.

This successful deployment marks a significant step for Dirui in delivering integrated laboratory solutions to the Latin American market and demonstrates the growing international recognition of China’s IVD technologies in supporting public health services abroad.